Conference
ARTEMIDE-Lung02: A Phase 3 Global Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for 1L Metastatic Squamous NSCLC
Authors
Lu S; Bestvina CM; Goksu SS; Goto Y; Hiltermann TJN; Mascaux C; Zhou Q; Aroldi F; Gong M; Lakhanpal M
Volume
20
Publisher
ELSEVIER SCIENCE INC
Publication Date
October 1, 2025
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
Issue
10
ISSN
1556-0864